Matinas Biopharma I (MTNB) Market Performance
- Trading Day: 23 May 2026, 24‑hour period ending 09:59 AM CET
- Price Movement: Up 12.5 %
- Current Price: USD 1.71 per share
- Shares Outstanding: 6.4 million
- Market Capitalisation: USD 1.5 million
- Volume (Last 24 h): USD 82.8 k
- Year‑to‑Date Gain: 877.14 % since the end of the previous month
- 200‑Day Simple Moving Average: USD 0.78
- 52‑Week Range:
- High: USD 6.6 (29 July 2026)
- Low: USD 0.15 (15 September 2026)
Recent 24‑Hour Performance of Related Stocks
| Ticker | Current Price | % Change | Market Cap | Notes |
|---|---|---|---|---|
| CRIS | USD 0.40 | +2.56 % | USD 1.6 million | – |
| OLOX | USD 0.91 | –9.7 % | USD 1.7 million | New three‑phase plan to expand Bitcoin‑mining operations; aims to increase miner fleet from ~9,700 to 20,000 using self‑generated power. |
| IPDN | USD 2.53 | –3.44 % | USD 1.7 million | – |
| NXL | USD 2.03 | –5.14 % | USD 1.7 million | – |
| GNPX | USD 1.98 | –3.41 % | USD 1.7 million | – |
Company Profile
Matinas BioPharma Holdings, Inc. is a holding company that supplies clinical‑stage biopharmaceutical services through its subsidiaries. The company is headquartered in Bedminster, United States, and operates in the Health Care sector with a focus on Biotechnology. Its portfolio includes small‑molecule drugs, oligonucleotides, vaccines, peptides, proteins, and other medicinal products. The company’s website is www.matinasbiopharma.com , and it trades on the NYSE MKT under the ticker MTNB.
